Cancer ‘sponge’ tests for bad indigestion could be offered to more people

by | Nov 22, 2026 | Health

Cancer 'sponge' tests for bad indigestion could be offered to more people

New draft guidance from the National Institute for Health and Care Excellence recommends that the NHS in England expand access to minimally invasive sponge tests for detecting oesophageal cancer among patients experiencing chronic indigestion. The tests, which can be administered in general practice settings within minutes, represent a less invasive alternative to traditional hospital-based endoscopy procedures that employ small cameras to visualize internal structures.

The sponge test procedure involves patients swallowing a small dissolving capsule with an attached thread. Once the capsule reaches the stomach, it releases a tiny sponge that collects cells from the oesophageal lining as the device is gently withdrawn through the mouth by a clinician. These collected cells are subsequently analyzed for abnormalities. While sponge tests are currently available in select locations across England, the guidance suggests expanding their availability nationwide.

Barrett’s oesophagus, a condition where cells lining the oesophagus undergo changes, frequently accompanies heartburn and acid reflux and can increase long-term cancer risk. Estimates suggest between one and two adults in every 100 has the condition, though most do not eventually develop cancer. High demand for NHS endoscopy services has resulted in some patients with Barrett’s oesophagus not receiving monitoring at recommended intervals.

According to NICE leadership, expanded use of sponge tests could improve patient outcomes by providing a quick, less invasive method for identifying concerning cellular changes and determining which patients require additional diagnostic procedures. NHS England officials noted that pilot programs involving thousands of participants have demonstrated the test’s efficiency and potential to reduce reliance on more complex endoscopy procedures while freeing resources for earlier-stage cancer detection.

NICE emphasized that no diagnostic test, including endoscopy, detects every case, and patients receiving normal sponge test results require continued long-term monitoring. Final recommendations are expected in the new year.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI